(Circulation. 1999;100:2237.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Cardiology, Department of Medicine, National Yang-Ming University, School of Medicine, and Veterans General Hospital-Taipei (Z.-C.W., C.-H.W., C.-T.T., C.-F.T., Y.-A.D., M.-S.C., S.-A.C.), and Kaohsiung (C.-W.C.), Taiwan, ROC, and the Division of Cardiovascular Medicine, Taipei Medical College and Taipei Wan-Fang Hospital. Dr Hsieh is currently with the Division of Cardiovascular Medicine, Taipei Medical College and is affiliated with Taipei Wan-Fang Hospital.
Correspondence to Shih-Ann Chen, MD, Division of Cardiology, Veterans General Hospital-Taipei, 201 Sec 2, Shih-Pai Road, Taipei, Taiwan, ROC. E-mail sachen{at}vghtpe.gov.tw
| Abstract |
|---|
|
|
|---|
Methods and ResultsThirty-seven patients with paroxysmal AF were referred for ablation. The study group included 30 patients who underwent transseptal ablation of PVs, and the control group included 7 patients who underwent the transseptal procedure without ablation. The mean sinus rate and time-domain (standard deviation of RR intervals and root-mean-square of differences of adjacent RR intervals) and frequency-domain (low frequency, high frequency, and low-frequency/high-frequency ratio) analyses of HRV were obtained by use of 24-hour Holter monitoring before and 1 week, 1 month, and 6 months after ablation. All the triggering points of AF were from PVs, and they were successfully ablated. Severe bradycardia and hypotension were noted during ablation of PVs in 6 patients (group IA); 24 patients without the above complication belonged to group IB. Compared with preablation values, a significant increase in mean sinus rate and low-frequency/high-frequency ratio and a significant decrease in standard deviation of RR intervals, root-mean-square of differences of adjacent RR intervals, low frequency, and high frequency were noted in groups IA and IB patients 1 week after ablation. The changes in HR and HRV recovered spontaneously in the 2 subgroups by 1 month later. These parameters of HRV did not change in the control group after the transseptal procedure.
ConclusionsTransient autonomic dysfunction with alterations in HR and HRV occurred after ablation of focal AF originating from PVs.
Key Words: fibrillation veins ablation
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Twenty-Four-Hour Holter Monitoring
All the patients received ambulatory 24-hour Holter monitoring
before, 1 week, and 1 and 6 months after focal ablation of PVs. We did
not perform Holter monitoring 1 day after ablation, because
postprocedural pain, hypovolemia, and anxiety may contribute to the
alterations in HR and HRV.1 Holter monitoring was
performed using a 3-channel bipolar recorder and was evaluated
after digitization by an Oxford Medilog Excel II analysis
system. For each hour, the following data were computed and tabulated:
maximal and minimal HR; total number of ventricular
premature beats, including couplets and ventricular
tachycardia; and total number of
supraventricular premature beats. The mean sinus rate was
derived from the mean RR intervals (after exclusion of abnormal beats),
and the maximal sinus rate was derived from the maximal HR after
exclusion of nonsinus rhythm. Inappropriate sinus
tachycardia was defined as a resting mean sinus rate of
>100 bpm without physiological or
hemodynamic causes.
Heart Rate Variability
The analysis technique has been well established in this
laboratory.11 12 In brief, HRV was analyzed from
the Holter recordings using a commercially available software
algorithm (Oxford Medilog Excel II). During the analysis, only
normal beats were measured, and all artifacts or extrasystolic
beats were eliminated. The beat classification was verified, manually
overread, and corrected appropriately by an experienced cardiologist.
The beats before the onset of AF (total, 30 seconds), during the AF
episode, and after the termination of AF (total, 30 seconds) were also
excluded. All the beats of exclusion must be <1% of totally available
beats. The time-domain measures of HRV, including standard deviation of
RR intervals (SDRR) and root-mean-square of differences of adjacent RR
intervals (rMSSD), were obtained by using the continuous data
throughout 24 hours. The frequency-domain analysis of HRV was
performed by a fast Fourier transform of the RR intervals, which
produced a power spectrum from the 0.01- to 1.0-Hz unit (1 cycle per
second). Three frequency-domain measures of HRV, including low
frequency (LF; range, 0.04 to 0.15 Hz), high frequency (HF; range, 0.15
to 0.40 Hz), and LF/HF ratio were calculated. The SDRR, rMSSD, and HF
are known to reflect the activity of the parasympathetic nervous
system, and LF/HF ratio is interpreted to be a marker of sympathovagal
balance.11 12 13 14 15
Electrophysiological Study and Catheter
Ablation
As described previously, 2 multipolar electrode catheters were
placed in the anterolateral right atrium and His bundle area for
recording and pacing.10 A 7F decapolar catheter
was inserted into the coronary sinus. After a successful atrial
transseptal puncture, 2 exchange guidewires were introduced into the
left atrium through the interatrial septum, and then 2 long sheaths (8F
SR0 for left superior pulmonary vein [LSPV] and 8.5F SL1 for
right superior pulmonary vein [RSPV]; Daig Co) were
advanced along the guidewires into the left atrium. Two 6F decapolar
catheters were put into the RSPV and LSPV, guided by the
pulmonary venography (Figure 1
).
Intravenous heparin was administered at a dosage of 1000 to
2000 U at 1-hour intervals, if needed, to maintain activated
clotting time >250 seconds after the atrial transseptal procedure.
|
Because these patients were suspected to have spontaneous onset of AF,
we first tried to find spontaneous AF at the baseline or after infusion
of isoproterenol (
4 µg/min). If spontaneous AF did not appear, a
short duration of burst pacing from right atrium and coronary
sinus was used to facilitate spontaneous AF onset during isoproterenol
infusion. If spontaneous AF could not be initiated, high-current burst
pacing from right atrium or coronary sinus was used to induce
AF; after the episode of pacing-induced AF was sustained for >5
minutes, external cardioversion was attempted to convert AF to sinus
rhythm and observe the spontaneous reinitiation of AF. The methods used
to induce spontaneous AF were tried at least twice to ensure
reproducibility. The details of these techniques have been described in
our laboratory.10
The presumed ablation site was chosen on the basis of the earliest
bipolar activity of the triggering ectopic beats preceding AF from PVs
(Figure 2
). The ablation catheter (4-mm
tip electrode, Mansfield, Boston Scientific) was put into the PV with 1
guiding catheter in situ, and ablation was performed. A temperature
control model with maximal temperature setting of 60°C was used. Each
application of RF energy was delivered for 20 to 40 seconds.
Application of energy was stopped immediately if the patients felt
burning pain or bradycardia and/or hypotension occurred. Procedural
success was defined as that AF was noninducible with the same protocols
before ablation.
|
Postablation Follow-Up
All the procedures and follow-up studies were performed at this
institution. Close clinical follow-up and 24-hour Holter monitoring (1
week, 1 month, and 6 months after ablation) were scheduled and
performed to assess the effects of catheter ablation.
Statistical Analysis
The parametric data were presented as mean±SD.
Comparisons of the parametric data among the groups obtained at
different time sequences were made by 1-way ANOVA with the Bonferroni
correction for comparison between means. An unpaired t test
was used to compare data among groups. A value of P<0.05
was considered statistically significant.
| Results |
|---|
|
|
|---|
All of the study patients had spontaneous initiation of AF, as follows: during the baseline observation (1 patient), after isoproterenol infusion (5), after a short duration of atrial pacing under isoproterenol infusion (11), or after cardioversion of pacing-induced AF (13). All of the triggering points of AF in the study group were from the PVs, including 12 in the LSPV, 8 in the RSPV, and 10 in the RSPV and LSPV. Successful ablation of the PVs was achieved in all patients. Severe bradycardia (HR <40 bpm), sinus arrest, or hypotension (systolic blood pressure <90 mm Hg) was noted during applications of RF to the PVs in 6 patients (group IA); the ablation site was 7±9 mm inside the LSPV (4 patients) or 9±13 mm inside the RSPV (2 patients). The other 24 patients without this complication during ablation belonged to group IB. The ablation site was 11±10 mm inside the LSPV (10 patients), 13±12 mm inside the RSPV (6), or both in the RSPV and LSPV (8). The mean number of RF applications was 9±5 in group IA and 7±3 in group IB patients. None of the patients had bradycardia-hypotension response during the transseptal puncture. Three patients (1 in group IA and 2 in group IB) had recurrent asymptomatic AF, which was noted during 1-month follow-up Holter monitoring. Because the duration of AF attack was short (all <1 minute) and the frequency of AF was less than before ablation, the patients did not need any antiarrhythmic drug.
Acute Changes in HRV
Comparisons with the baseline data before ablation, the mean sinus
rate, and maximal sinus rate were significantly higher at 1 week after
ablation of PVs in groups IA and IB
(Table
). Two patients (6.7%)
presented with inappropriate sinus tachycardia
(mean sinus rate increased from 83 and 79 bpm to 110 and 104 bpm,
respectively). SDRR, rMSSD, LF, and HF were all significantly decreased
after ablation in the 2 subgroups; LF/HF ratio was also increased
significantly. Furthermore, these parameters obtained
before or after ablation were similar between groups IA and IB
patients. In group II patients, no significant change occurred among
the parameters obtained at baseline and 1 week after the
transseptal procedure.
|
Chronic Changes in HRV
One month after ablation, the mean and maximal sinus rates of all
the study patients (including the 2 patients with inappropriate sinus
tachycardia) returned to the baseline level; no significant
change of the mean and maximal sinus rates was noted in the data before
and 1 month after ablation (Figure 3A
).
SDRR, rMSSD, LF, HF, and LF/HF were not significantly different in the
data obtained at before and 1 month after ablation (Figures 3B
through 3F). These changes showed the same trends in groups IA and IB.
The HRV parameters obtained at 6 months after ablation were
similar compared with those obtained at baseline and 1 month after
ablation (Figures 3A
through 3F).
|
| Discussion |
|---|
|
|
|---|
Autonomic Dysfunction After Ablation of PVs
Previous studies have reported inappropriate sinus
tachycardia as a complication after ablation of
supraventricular
tachycardias.1 2 16 17 18 19 Some possible
mechanisms have been discussed, and a change of autonomic tone is the
most likely explanation in these reports. These researchers used HRV to
evaluate the autonomic function and found that parasympathetic nervous
withdrawal occurred after ablation of supraventricular
tachycardias.1 2 3 4 5 6 16 17 18 19 In the present
study, the prevalence of inappropriate sinus tachycardia
was 6.7%, similar to that in previous reports regarding ablation of
supraventricular
tachycardias.1 2 3 17 18 We also found
decreases in SDRR, rMSSD, and HF and increases in mean and maximal
sinus rate and LF/HF ratio, which indicates autonomic dysfunction, just
like the findings after ablation of supraventricular
tachycardias. Furthermore, no significant changes in HR and
HRV were noted in our control group, which indicates autonomic
dysfunction after ablation of PVs was not related to the transseptal
procedure.
Although autonomic dysfunction may play an important role in changes in
HR and HRV after ablation of slow pathway, posteroseptal
space, and PVs, the precise mechanism is not clear. An increase of
sympathetic tone, a decrease of parasympathetic tone, or a combination
of both factors is the possible explanations. Ardell and
Randall20 have shown in the canine heart that the
intrapericardial projections of the left vagus to the sinus node
penetrate the epicardium in the region of the common PV complex.
Furthermore, the projections of the right vagus penetrate
epicardium adjacent to the origin of the right PV.21 22 23
Recently, Marron et al24 identified widely distributed
specialized nerve terminals in the human heart, and numerous
nonmyelinated C-fibers terminals, which are believed to be
responsible for cardiac depressing baroreflexes, were identified in the
roof of the left atrium and around the 4 PVs. Therefore, focal ablation
of PVs could result in stimulation (induced bradycardia-hypotension
response) or destruction (induced parasympathetic nervous withdrawal or
denervation) of postganglionic parasympathetic fibers or specialized
nerve terminals in PVs, which are destined to innervate the
sinus node (Figure 4
).25
|
The other possibility of changes in HR and HRV is mediated by cardiac
sympathovagal (so-called cardiocardiac) reflex.26 In acute
myocardial infarction, the necrotic scar alters the geometry of the
beating heart, which results in an increased activity of sympathetic
afferent fibers secondary to distortion of their sensory endings; this
change produces an inhibition of vagal efferent activity to the heart
(including the sinus node) and increases efferent sympathetic activity.
Therefore, an increase in HR and a decrease in HRV after myocardial
infarction are the results of an enhanced sympathetic activity and
parasympathetic nervous withdrawal. Some previous reports have
demonstrated that cardiac sympathetic nerves form an important afferent
pathway and the receptor endings of the fibers consist of free
terminals scattered diffusely in the heart.22 26 27 28 These
sympathetic fibers are distributed throughout the atria, but the vagal
branches have a more-limited distribution to specific sites. This
explains why multiple lesions in the atria (including slow
atrioventricular node, para-hisian pathway,
posteroseptal space, and PVs) affect preferentially the
sympathetic endings and elicit an increase in HR and a decrease in HRV
(Figure 5
). Vagal fiber endings would be
less affected.
|
Relation Between Parasympathetic Stimulation and Autonomic
Dysfunction Caused by RF Energy
Friedman et al1 have shown that ablation of slow
pathway or posteroseptal area could result in profound
sinus bradycardia. They suggested that RF current directly stimulated
parasympathetic fibers traveling from the site of RF application to the
sinus node. The finding was similar to that of our previous report
regarding the effect of direct intracardiac stimulation of human
afferent vagal fibers.29 Because focal ablation of
supraventricular tachycardias could result in
stimulation of parasympathetic nerve fibers or terminals, the presence
of a bradycardia-hypotension phenomenon may be related to the
distribution and density of parasympathetic nerve fibers around the
ablation areas. Previous animal and human studies have demonstrated
numerous parasympathetic nerve terminals in the PV area, and the
incidence of ablation-induced bradycardia-hypotension response was
higher than with ablation of other atrial
tissues.2 9 20 21 22 23 24 In the present study, we found no
significant difference in HR and HRV between patients with
bradycardia-hypotension response and those without this complication
during ablation of PVs. The 2 subgroups showed transient autonomic
dysfunction after ablation. This finding suggested that transient
autonomic dysfunction occurred even in the absence of
bradycardia-hypotension response (parasympathetic stimulation) during
ablation of PVs.
Recovery of Autonomic Dysfunction After Ablation of PVs
Previous reports showed that autonomic dysfunction developed
immediately after ablation of slow pathway or posteroseptal
area and spontaneous resolution of HRV occurred 1 to 6 months
later.1 2 3 4 5 6 Therefore, we performed 24-hour Holter
monitoring at 1 and 6 months after ablation of PVs, respectively, to
see the chronic changes in HRV. The results showed that an increase in
HR and a decrease in HRV recovered at 1 month after ablation of PVs,
indicating a transient dysfunction of autonomic nervous system, just as
the findings after ablation of supraventricular
tachycardias.
Clinical Implications
The present study provided some clinical implications in the
patients who underwent ablation of PVs. First, the incidence of
bradycardia-hypotension response induced by the transseptal puncture
was low, and no evidence of autonomic dysfunction after the transseptal
procedure was noted in the present study.30
However, focal PV ablation could induce a higher incidence of
bradycardia-hypotension response and transient autonomic dysfunction.
The transient alterations of autonomic function could explain the
possible mechanism of palpitation (sinus tachycardia,
without recurrence of paroxysmal AF) after ablation of PVs.
Second, the change in autonomic function with enhanced sympathetic tone
or parasympathetic withdrawal could cause atrial premature beats
and spontaneous AF.
Study Limitations
The present study had several limitations. First, HRV is used
to evaluate the variability of sinus node, and all of the beats not
from the sinus node should be eliminated. Our patients had frequent
attacks of paroxysmal AF, and the patients with abnormal beats that
were >1% of the available beats were excluded. Thus, the patients
with very frequent attacks of AF were not included. On the other hand,
in patients with recurrence of AF after ablation of PVs who had
abnormal beats that were >1% of sinus beats were also excluded.
Otherwise, an increase in HR and a decrease in HRV might result from
elevated sympathetic activity, decreased parasympathetic activity, or a
combination of the 2 factors. Any factor that could affect autonomic
tone also interfered with the HRV; these factors included
postprocedural hypovolemia, pain, emotional stress, and some drugs
(such as sedative or isoproterenol used during the procedure). To avoid
the effects of these factors, we performed postablation 24-hour Holter
monitoring 1 week after ablation. Finally, we could not rule out the
possibility that the autonomic dysfunction was induced by transient
edema of autonomic nerve fibers after PV ablation.
Conclusions
Focal ablation of PVs could result in an increase in HR and a
decrease in time-domain and frequency-domain measures of HRV, which
indicates autonomic dysfunction. These changes were transient and could
resolve spontaneously 1 month later, which represents recovery
of autonomic dysfunction.
| Acknowledgments |
|---|
Received March 10, 1999; revision received July 12, 1999; accepted July 20, 1999.
| References |
|---|
|
|
|---|
2.
Kocovic DZ, Harada T, Shea JB, Soroff D, Friedman PL.
Alterations of heart rate and of heart rate variability after
radiofrequency catheter ablation of supraventricular
tachycardia: delineation of parasympathetic pathways in the
human heart. Circulation. 1993;88:16711681.
3.
Madrid AH, Mestre JL, Moro C, Vivas E, Tejero I, Novo
L, Marin E, Orellana L. Heart rate variability and inappropriate sinus
tachycardia after catheter ablation of
supraventricular tachycardia. Eur
Heart J. 1995;16:16371640.
4. Pappone C, Stabile G, Oreto G, de Simone A, Rillo M, Mazzone P, Cappato R, Chierchia S. Inappropriate sinus tachycardia after radiofrequency ablation of para-hisian accessory pathways. J Cardiovasc Electrophysiol. 1997;8:13571365.[Medline] [Order article via Infotrieve]
5. Soejima K, Akaishi M, Mitamura H, Ogawa S, Sakurada H, Okazaki H, Motomiya T, Hiraoka M. Increase in heart rate after radiofrequency catheter ablation is mediated by parasympathetic nervous withdrawal and related to site of ablation. J Electrocardiol. 1997;30:239246.[Medline] [Order article via Infotrieve]
6. Geller C, Goette A, Carlson MD, Esperer HD, Hartung WM, Auricchio A, Klein HU. An increase in sinus rate following radiofrequency energy application in the posteroseptal space. Pacing Clin Electrophysiol. 1998;21:303307.[Medline] [Order article via Infotrieve]
7.
Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L,
Hocini M, Clementy J. A focal source of atrial fibrillation treated by
discrete radiofrequency ablation. Circulation. 1997;95:572576.
8.
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini
M, Quiniou G, Garrigue S, Mouroux AL, Metayer PL, Clementy J.
Spontaneous initiation of atrial fibrillation by ectopic beats
originating in the pulmonary veins. N Engl J
Med. 1998;339:659666.
9. Tsai CF, Chen SA, Tai CT, Chiou CW, Prakash VS, Yu WC, Hsieh MH, Ding YA, Chang MS. Bezold-Jarisch-like reflex during radiofrequency ablation of the pulmonary vein tissues in patients with paroxysmal focal atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:2735.[Medline] [Order article via Infotrieve]
10. Hsieh MH, Chen SA, Tai CT, Tsai CF, Prakash VS, Yu WC, Liu CC, Ding YA, Chang MS. Double multielectrode mapping catheters facilitate radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. J Cardiovasc Electrophysiol. 1999;10:136144.[Medline] [Order article via Infotrieve]
11.
Wen ZC, Chen SA, Tai CT, Huang JL, Chang MS. Role of
autonomic tone in facilitating spontaneous onset of typical atrial
flutter. J Am Coll Cardiol. 1998;31:602607.
12.
Chen YJ, Chen SA, Tai CT, Wen ZC, Feng AN, Ding YA,
Chang MS. Role of atrial electrophysiology and autonomic nervous system
in patients with supraventricular tachycardia
and paroxysmal atrial fibrillation. J Am Coll Cardiol. 1998;32:732738.
13.
Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC,
Cohen RJ. Power spectrum analysis of heart rate fluctuation: a
quantitative probe of beat-to-beat cardiovascular
control. Science. 1981;213:220222.
14.
Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D,
Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H.
Assessment of autonomic function in humans by heart rate spectral
analysis. Am J Physiol. 1985;248:H151H153.
15.
Task Force of the European Society of
Cardiology and the North American Society of Pacing and
Electrophysiology. Heart rate variability: standards of measurement,
physiological interpretation, and clinical use.
Circulation. 1996;93:10431065.
16.
Kay GN, Epstein AE, Dailey SM, Plumb VJ. Selective
radiofrequency ablation of slow pathway for the treatment of
atrioventricular nodal reentrant
tachycardia: evidence for involvement of perinodal
myocardium within the reentrant circuit.
Circulation. 1992;85:16751688.
17. Ehlert FA, Goldberger JJ, Brooks R, Miller S, Kadish AH. Persistent inappropriate sinus tachycardia after radiofrequency current catheter modification of the atrioventricular node. Am J Cardiol. 1992;62:10921095.
18. Skeberis V, Simonis F, Tsakonas K, Celiker A, Andries E, Brugada P. Inappropriate sinus tachycardia following radiofrequency catheter ablation of AV nodal tachycardia: Incidence and clinical significance. Pacing Clin Electrophysiol. 1994;17:924927.[Medline] [Order article via Infotrieve]
19.
Natale A, Klein G, Yee R. Shortening of fast pathway
refractoriness after slow pathway ablation: effects of autonomic
blockade. Circulation. 1994;89:11031108.
20. Ardell JL, Randall WC. Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart. Am J Physiol. 1986;20:H764H773.
21.
Lazzara R, Scherlag BJ, Robinson MJ, Samet P. Selective
in situ parasympathetic control of the canine sinoatrial and
atrioventricular nodes. Circ Res. 1973;32:393401.
22. Randall WC, Ardell JL. Nervous control of the heart: anatomy and pathophysiology. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology, From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1990:291299.
23.
Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation
of the canine atria and sinus and atrioventricular
nodes: the third fat pad. Circulation. 1997;95:25732584.
24.
Marron K, Wharton J, Sheppard MN, Fagan D,
Royston D, Kuhn DM, de Leval MR, Whitehead BF, Anderson RH, Polak JM.
Distribution, mor-phology, and neurochemistry of endocardial and
epicardial nerve terminal arborizations in the human heart.
Circulation. 1995;92:23432351.
25.
Chiou CW, Zipes DP. Selective vagal denervation of the
atria eliminates heart rate variability and baroreflex sensitivity
while preserving ventricular innervation.
Circulation. 1998;98:360368.
26.
Schwartz PJ, Pagani M, Lombardi F, Malliani A, Brown
AM. A cardiac sympathovagal reflex in the cat. Circ Res. 1973;32:215220.
27. Kostreva DR, Zuperku EJ, Purtock RV, Coon RL, Kampine JP. Sympathetic afferent nerve activity. Am J Physiol. 1975;229:911915.
28.
Malliani A, Peterson DF, Bishop VS, Brown AM. Spinal
sympathetic cardiovascular reflexes. Circ
Res. 1972;30:158166.
29. Chen SA, Chiang CE, Tai CT, Wen ZC, Lee SH, Chiou CW, Ding YA, Chang MS. Intracardiac stimulation of human parasympathetic nerve fibers induce negative dromotropic effects: implication with the lesions of radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 1998;9:245252.[Medline] [Order article via Infotrieve]
30. Croft CH, Lipscomb K. Modified technique of transseptal left heart catheterization. J Am Coll Cardiol. 1985;5:904910.[Abstract]
This article has been cited by other articles:
![]() |
M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyanaga, T. Yamane, T. Date, M. Tokuda, Y. Aramaki, K. Inada, K. Shibayama, S. Matsuo, H. Miyazaki, K. Abe, et al. Impact of pulmonary vein isolation on the autonomic modulation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses Europace, May 1, 2009; 11(5): 576 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ketels, R. Houben, K. Van Beeumen, R. Tavernier, and M. Duytschaever Incidence, timing, and characteristics of acute changes in heart rate during ongoing circumferential pulmonary vein isolation Europace, December 1, 2008; 10(12): 1406 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pokushalov, A. Turov, P. Shugayev, S. Artyomenko, A. Romanov, and N. Shirokova Catheter Ablation of Left Atrial Ganglionated Plexi for Atrial Fibrillation Asian Cardiovasc Thorac Ann, June 1, 2008; 16(3): 194 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arora, J. S. Ulphani, R. Villuendas, J. Ng, L. Harvey, S. Thordson, F. Inderyas, Y. Lu, D. Gordon, P. Denes, et al. Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H134 - H144. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF] |
||||
![]() |
J.-Y. Kuo and S.-A. Chen Is Vagal Denervation a Good Alternative or Just Adjunctive to Pulmonary Vein Isolation in Catheter Ablation of Atrial Fibrillation? J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1349 - 1351. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
M. Scanavacca, C. F. Pisani, D. Hachul, S. Lara, C. Hardy, F. Darrieux, I. Trombetta, C. E. Negrao, and E. Sosa Selective Atrial Vagal Denervation Guided by Evoked Vagal Reflex to Treat Patients With Paroxysmal Atrial Fibrillation Circulation, August 29, 2006; 114(9): 876 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
A. Y. Tan, H. Li, S. Wachsmann-Hogiu, L. S. Chen, P.-S. Chen, and M. C. Fishbein Autonomic Innervation and Segmental Muscular Disconnections at the Human Pulmonary Vein-Atrial Junction: Implications for Catheter Ablation of Atrial-Pulmonary Vein Junction J. Am. Coll. Cardiol., July 4, 2006; 48(1): 132 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jahangiri, G. Weir, K. Mandal, I. Savelieva, and J. Camm Current strategies in the management of atrial fibrillation. Ann. Thorac. Surg., July 1, 2006; 82(1): 357 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilsson, X. Chen, S. Pehrson, Jør. Hilden, and J. H. Svendsen Increased resting heart rate following radiofrequency catheter ablation for atrial fibrillation Europace, January 1, 2005; 7(5): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Grossman, F. H. Wilhelm, and M. Spoerle Respiratory sinus arrhythmia, cardiac vagal control, and daily activity Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H728 - H734. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pappone, G. Oreto, S. Rosanio, G. Vicedomini, M. Tocchi, F. Gugliotta, A. Salvati, C. Dicandia, M. P. Calabro, P. Mazzone, et al. Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation: Efficacy of an Anatomic Approach in a Large Cohort of Patients With Atrial Fibrillation Circulation, November 20, 2001; 104(21): 2539 - 2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.A. Chen, C.T. Tai, M.H. Hsieh, C.F. Tsai, Y.A. Ding, and M.S. Chang Radiofrequency catheter ablation of atrial fibrillation initiated by spontaneous ectopic beats Europace, January 1, 2000; 2(2): 99 - 105. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |